Top

Published in:

01-12-2021 | Human Immunodeficiency Virus | Commentary

Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy

Author: Beth A. Tippett Barr

Published in: BMC Medicine | Issue 1/2021

Excerpt

The World Health Organization’s comprehensive strategic approach to prevention of mother-to-child transmission of HIV (PMTCT) covers the “4-prongs” of PMTCT programming: primary prevention of HIV; prevention of unintended pregnancies; prevention of vertical transmission from mother to infant; and provision of treatment, care, and support to mothers and infants [1, 2]. …

World Health Organization, Department of HIV/AIDS prevention of mother-to-child transmission (PMTCT) Briefing Note October 1st, 2007. Available at Microsoft Word - PMTCT Generic Briefing.doc (who.int)

World Health Organization, HIV/AIDS Programme. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Towards universal access. 2006. Available at ARVPregnantWomen.indd (who.int)

Kenya Ministry of Health. Kenya Essential Medicines List (KEML). 2019. Available at KEML 2019_full ver, 13th Dec 2019.indd (health.go.ke)

Patel RC, Amorim G, Jakait B, Shepherd BE, Mocello AR, Musick B, et al. Pregnancies among women living with HIV using contraceptives and antiretroviral therapy in western Kenya: a retrospective, cohort study. BMC Medicine. 2021; publication pending.

Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 2018;379(10):979–81. https://doi.org/10.1056/NEJMc1807653.CrossRefPubMedPubMedCentral

Patel RC, Onono M, Gandhi M, Blat C, Hagey J, Shade SB, et al. Pregnancy rates in HIV positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Lancet HIV. 2015;2(11):e474–82. https://doi.org/10.1016/S2352-3018(15)00184-8.CrossRefPubMedPubMedCentral

Personal conversation

Title: Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy
Author: Beth A. Tippett Barr
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Human Immunodeficiency Virus
Published in: BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-021-02066-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL

m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

The effects of selected inhibitors on human fetal adrenal steroidogenesis differs under basal and ACTH-stimulated conditions

Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts

Optimal site for fluoroscopic tracer injection for laparoscopic lymphadenectomy

Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study